Precision Biosciences

  • Modular synthetic meganuclease scaffold, called ARCUS, for easily adaptable genome editing
  • Meganucleases use large recognition sites – typically 20 base pairs to 50 base pairs long – for highly specific genome editing
  • Claims development of highly specific meganucleases at the same...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email Thank you!

Related Research


Company Snapshot | September 09, 2021

The company was founded by Dror Shalitin, who holds a doctorate degree from the Hebrew University of Jerusalem, and a postdoctorate from the University of California, Los Angeles; Dror was previously a senior investigator at the Institute for Myeloma & Bone Cancer Research in the U.S. and a ... Not part of subscription

Hudson River Biotechnology

Company Profile | March 04, 2022

Hudson River Biotechnology (HRB) uses Cas9 and MAD7 gene editing platforms and claims to have improved efficiency with MAD7 The company utilizes ribonucleoproteins (RNPs) to carry the gene editing system and prevent introduction of foreign DNA It's currently developing a nanolipid ... Not part of subscription


Company Profile | May 19, 2022

Evogene developed a computational platform that uses machine learning algorithms to identify candidate genes, small molecules, and biologicals for agricultural applications Evogene forms strategic R&D partnerships to bring its identified candidates to market; the company is currently ... Not part of subscription